Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

The 2012 criteria are better for diagnosing atypical lupus cases.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Genetic discoveries are leading to new treatments for alopecia areata.

PAS III can cause multiple autoimmune diseases with noticeable skin issues.

ILC1 cells contribute to hair loss in alopecia areata.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Alopecia areata patients are more likely to develop systemic lupus erythematosus.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Different γδ T cell types have unique roles in causing alopecia areata.

RDW can be a useful marker for inflammation in alopecia areata patients.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

Alopecia areata may be linked to higher heart disease risk.

A woman with multiple autoimmune diseases showed improvement in hair loss but not in skin discoloration after treatment.

Higher inflammation markers are linked to more severe alopecia areata.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

Epigenetic changes contribute to autoimmune skin diseases.

CD44 variant changes start alopecia areata, but don't maintain it.

Four antibodies were developed to help study hair follicle cell differentiation.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Alopecia areata patients have a higher risk of other immune-related diseases.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.